Hypertension Diagnostics Stock Market Outlook
| HDII Stock | USD 0.0001 0.00 0.00% |
Under 56% of Hypertension Diagnostics' investor base is looking to short. The analysis of overall sentiment of trading Hypertension Diagnostics pink sheet suggests that many investors are alarmed at this time. Hypertension Diagnostics' investing sentiment shows overall attitude of investors towards Hypertension Diagnostics.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Hypertension Diagnostics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Hypertension Diagnostics.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Hypertension Diagnostics is 'Strong Sell'. The recommendation algorithm takes into account all of Hypertension Diagnostics' available fundamental, technical, and predictive indicators you will find on this site.
Execute Hypertension Diagnostics Advice
The Hypertension recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Hypertension Diagnostics. Macroaxis does not own or have any residual interests in Hypertension Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hypertension Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
For the selected time horizon Hypertension Diagnostics has a Return On Asset of 3.0E-4, Profit Margin of (0.03) %, Operating Margin of 0.0002 %, Current Valuation of 5.26 M, Shares Outstanding of 52.39 M and Price To Earning of (0.03) XWe provide advice to complement the regular expert consensus on Hypertension Diagnostics. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Hypertension Diagnostics is not overpriced, please check out all Hypertension Diagnostics fundamentals, including its net income, beta, net asset, as well as the relationship between the book value per share and working capital . As Hypertension Diagnostics appears to be a penny stock we also urge to confirm its price to sales numbers.
Hypertension Diagnostics Trading Alerts and Improvement Suggestions
| Hypertension Diagnostics generated a negative expected return over the last 90 days | |
| Hypertension Diagnostics has some characteristics of a very speculative penny stock | |
| Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K. | |
| Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations. |
Hypertension Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hypertension Diagnostics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hypertension Diagnostics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hypertension pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Hypertension Diagnostics Volatility Alert
At this time Hypertension Diagnostics exhibits very low volatility. Hypertension Diagnostics appears to be a penny stock. Although Hypertension Diagnostics may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Hypertension Diagnostics or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Hypertension instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Hypertension Diagnostics Fundamentals Vs Peers
Comparing Hypertension Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hypertension Diagnostics' direct or indirect competition across all of the common fundamentals between Hypertension Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hypertension Diagnostics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Hypertension Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Hypertension Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hypertension Diagnostics to competition |
| Fundamentals | Hypertension Diagnostics | Peer Average |
| Return On Asset | 3.0E-4 | -0.14 |
| Profit Margin | (0.03) % | (1.27) % |
| Operating Margin | 0.0002 % | (5.51) % |
| Current Valuation | 5.26 M | 16.62 B |
| Shares Outstanding | 52.39 M | 571.82 M |
| Price To Earning | (0.03) X | 28.72 X |
| Price To Sales | 0.15 X | 11.42 X |
| Revenue | 3.79 M | 9.43 B |
| Gross Profit | 954.47 K | 27.38 B |
| EBITDA | 72.29 K | 3.9 B |
| Net Income | (125.39 K) | 570.98 M |
| Cash And Equivalents | 5.66 K | 2.7 B |
| Total Debt | 4.69 M | 5.32 B |
| Current Ratio | 0.52 X | 2.16 X |
| Book Value Per Share | (0.09) X | 1.93 K |
| Cash Flow From Operations | (389.28 K) | 971.22 M |
| Earnings Per Share | (0) X | 3.12 X |
| Number Of Employees | 5 | 18.84 K |
| Beta | -0.92 | -0.15 |
| Market Capitalization | 730.42 K | 19.03 B |
| Total Asset | 1.28 M | 29.47 B |
| Retained Earnings | (30.68 M) | 9.33 B |
| Working Capital | (857 K) | 1.48 B |
| Current Asset | 277 K | 9.34 B |
| Current Liabilities | 1.13 M | 7.9 B |
| Z Score | -31.6 | 8.72 |
| Net Asset | 1.28 M |
Hypertension Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hypertension . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Hypertension Diagnostics Buy or Sell Advice
When is the right time to buy or sell Hypertension Diagnostics? Buying financial instruments such as Hypertension Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Hypertension Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Iron Thematic Idea Now
Iron
Companies involved in production of steel and iron. The Iron theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Hypertension Pink Sheet
Hypertension Diagnostics financial ratios help investors to determine whether Hypertension Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hypertension with respect to the benefits of owning Hypertension Diagnostics security.